Research & Literature

Effects of Helicobacter pylori Eradication in Chronic Spontaneous Urticaria: Results from a Retrospective Cohort Study.

Curth HM, Dinter J, Nigemeier K, et al.

American journal of clinical dermatology 2015; (16(6)):553-8 doi:10.1007/s40257-015-0152-6.

Unmet medical needs for chronic spontaneous urticaria patients: highlighting the real-life clinical practice in Taiwan.

Cho YT, Pao YC, Chu CY

Journal of the European Academy of Dermatology and Venereology : JEADV 2016; (30(1)):41-9 doi:10.1111/jdv.13357.

The Impact of Chronic Urticaria from the Patient's Perspective: A Survey in Five European Countries.

Balp MM, Vietri J, Tian H, Isherwood G

The patient 2015; (8(6)):551-8 doi:10.1007/s40271-015-0145-9.

Epidemiology of chronic spontaneous urticaria: results from a nationwide, population-based study in Italy.

Lapi F, Cassano N, Pegoraro V, et al.

The British journal of dermatology 2016; (174(5)):996-1004 doi:10.1111/bjd.14470.

Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema.

Maurer M, Sofen H, Ortiz B, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2017; (31(6)):1056-1063 doi:10.1111/jdv.14075.

Management of chronic spontaneous urticaria in routine clinical practice: A Delphi-method questionnaire among specialists to test agreement with current European guidelines statements.

Giménez-Arnau A, Ferrer M, Bartra J, et al.

Allergologia et immunopathologia 2017; (45(2)):134-144 doi:10.1016/j.aller.2016.06.007.

Management of Chronic Spontaneous Urticaria in Routine Clinical Practice Following the EAACI/GA(2)LEN/EDF/WAO Guidelines.

Marín-Cabañas I, Berbegal-de Gracia L, de León-Marrero F, et al.

Actas dermo-sifiliograficas 2017; (108(4)):346-353 doi:10.1016/j.ad.2016.12.012.

[Diagnostic and Therapeutic Approach of Chronic Spontaneous Urticaria: Recommendations in Portugal].

Costa C, Gonçalo M,

Acta medica portuguesa 2016; (29(11)):763-781 doi:10.20344/amp.8294.

Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria.

Finlay AY, Kaplan AP, Beck LA, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2017; (31(10)):1715-1721 doi:10.1111/jdv.14384.

Management of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcome.

Lima H, Gooderham M, Dutz J, et al.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2017; (13()):38 doi:10.1186/s13223-017-0210-0.

Cyclosporine for Chronic Spontaneous Urticaria: A Meta-Analysis and Systematic Review.

Kulthanan K, Chaweekulrat P, Komoltri C, et al.

The journal of allergy and clinical immunology. In practice 2018; (6(2)):586-599 doi:10.1016/j.jaip.2017.07.017.

The Urticaria Activity Score-Validity, Reliability, and Responsiveness.

Hawro T, Ohanyan T, Schoepke N, et al.

The journal of allergy and clinical immunology. In practice 2018; (6(4)):1185-1190.e1 doi:10.1016/j.jaip.2017.10.001.

Cost-effectiveness of omalizumab for the treatment of chronic spontaneous urticaria.

Kanters TA, Thio HB, Hakkaart L

The British journal of dermatology 2018; (179(3)):702-708 doi:10.1111/bjd.16476.

High-dose antihistamines for chronic spontaneous urticaria in adults.

Drug and therapeutics bulletin 2018; (56(4)):45-48 doi:10.1136/dtb.2018.4.0614.

Evaluating and managing chronic idiopathic urticaria in adults.

Webster L, Rider NL, Archambault ME

JAAPA : official journal of the American Academy of Physician Assistants 2018; (31(7)):22-26 doi:10.1097/01.JAA.0000534976.46365.11.

Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE study.

Bérard F, Ferrier Le Bouedec MC, Bouillet L, et al.

The British journal of dermatology 2019; (180(1)):56-66 doi:10.1111/bjd.16904.

Adaptation and Validation of the Korean Version of the Urticaria Control Test and Its Correlation With Salivary Cortisone.

Lee JH, Bae YJ, Lee SH, et al.

Allergy, asthma & immunology research 2019; (11(1)):55-67 doi:10.4168/aair.2019.11.1.55.

Real-life data on the effectiveness and safety of omalizumab in monotherapy or combined for chronic spontaneous urticaria: a retrospective cohort study.

Salman A, Ergun T, Gimenez-Arnau AM

The Journal of dermatological treatment 2020; (31(2)):204-209 doi:10.1080/09546634.2019.1589639.

Validation of the Turkish version of the Urticaria Control Test: Correlation with other tools and comparison between spontaneous and inducible chronic urticaria.

Kocatürk E, Kızıltaç U, Can P, et al.

The World Allergy Organization journal 2019; (12(1)):100009 doi:10.1016/j.waojou.2018.11.007.

A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria: a real-world study in Belgium.

Lapeere H, Baeck M, Stockman A, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2020; (34(1)):127-134 doi:10.1111/jdv.15684.

Consensus on the diagnostic and therapeutic management of chronic spontaneous urticaria in adults - Brazilian Society of Dermatology.

Criado PR, Maruta CW, Alchorne AOA, et al.

Anais brasileiros de dermatologia 2019; (94(2 Suppl 1)):56-66 doi:10.1590/abd1806-4841.2019940209.

Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study.

Schoepke N, Asero R, Ellrich A, et al.

Allergy 2019; (74(12)):2427-2436 doi:10.1111/all.13949.

Cutaneous manifestations of angioimmunoblastic T-cell lymphoma.

Hoskins S, Moriarty N, White K, et al.

Dermatology online journal 2019; (25(7)).

Evidence for bradykinin release in chronic spontaneous urticaria.

Hofman ZLM, van den Elzen MT, Kuijpers J, et al.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2020; (50(3)):343-351 doi:10.1111/cea.13558.

Diagnosis and treatment of chronic spontaneous urticaria.

Kaplan AP

Allergy 2020; (75(7)):1830-1832 doi:10.1111/all.14192.

A Meta-Analysis of Observational Studies on the Association of Chronic Urticaria With Symptoms of Depression and Anxiety.

Huang Y, Xiao Y, Zhang X, et al.

Frontiers in medicine 2020; (7()):39 doi:10.3389/fmed.2020.00039.

Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety.

Ocak M, Soyer O, Buyuktiryaki B, et al.

Allergologia et immunopathologia 2020; (48(4)):368-373 doi:10.1016/j.aller.2020.03.011.

The Arabic Urticaria Activity Score and Chronic Urticaria Quality of Life Questionnaire: validation and correlations.

Tawil S, Irani C, Kfoury R, et al.

International journal of dermatology 2020; (59(8)):893-901 doi:10.1111/ijd.15006.

Efficacy of omalizumab treatment for pediatric chronic spontaneous urticaria: A multi-center retrospective case series.

Ari A, Levy Y, Segal N, et al.

Pediatric dermatology 2020; (37(6)):1051-1054 doi:10.1111/pde.14360.

Autologous serum skin test reactions in chronic spontaneous urticaria differ from heterologous cell reactions.

Baumann K, Marcelino J, Skov PS, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2021; (35(6)):1338-1345 doi:10.1111/jdv.17131.

Histopathology of chronic spontaneous urticaria with occasional bruising lesions is not significantly different from urticaria with typical wheals.

Batista M, Calado R, Gil F, et al.

Journal of cutaneous pathology 2021; (48(8)):1020-1026 doi:10.1111/cup.13985.

Use of biologics in chronic spontaneous urticaria - beyond omalizumab therapy?

Metz M, Maurer M

Allergologie select 2021; (5()):89-95 doi:10.5414/ALX02204E.

Comparison of immunoglobulin E anti-thyroid peroxidase antibodies in patients with Hashimoto thyroiditis and chronic spontaneous urticaria.

Çildağ S, Yenisey Ç, Ünübol M, Şentürk T

Medicine and pharmacy reports 2021; (94(1)):53-57 doi:10.15386/mpr-1598.

Management of Pediatric Chronic Spontaneous Urticaria: A Review of Current Evidence and Guidelines.

Chang J, Cattelan L, Ben-Shoshan M, et al.

Journal of asthma and allergy 2021; (14()):187-199 doi:10.2147/JAA.S249765.

The Relation of Autologous Serum Skin Test and Autologous Plasma Skin Test Result with Various Clinical and Laboratory Findings in Patients with Chronic Spontaneous Urticaria.

Park GH, Choi JH, Kim S, Bae Y

Annals of dermatology 2020; (32(4)):280-288 doi:10.5021/ad.2020.32.4.280.

Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous Urticaria.

Kolkhir P, Altrichter S, Asero R, et al.

Allergy, asthma & immunology research 2021; (13(4)):545-559 doi:10.4168/aair.2021.13.4.545.

The Classification, Pathogenesis, Diagnostic Workup, and Management of Urticaria: An Update.

Maurer M, Zuberbier T, Metz M

Handbook of experimental pharmacology 2022; (268()):117-133 doi:10.1007/164_2021_506.

The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.

Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al.

Allergy 2022; (77(3)):734-766 doi:10.1111/all.15090.

Biomarkers associated with chronic spontaneous urticaria severity in 108 children.

Zhang L, Le M, Gabrielli S, et al.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2022; (33(2)):e13727 doi:10.1111/pai.13727.

Autoimmune chronic spontaneous urticaria.

Kolkhir P, Muñoz M, Asero R, et al.

The Journal of allergy and clinical immunology 2022; (149(6)):1819-1831 doi:10.1016/j.jaci.2022.04.010.

Detection of serum IgG autoantibodies to FcεRIα by ELISA in patients with chronic spontaneous urticaria.

Jang JH, Moon J, Yang EM, et al.

PloS one 2022; (17(8)):e0273415 doi:10.1371/journal.pone.0273415.

Omalizumab treatment for chronic spontaneous urticaria: data from Turkey.

Kara RO, Dikicier BS, Yaldiz M, et al.

Postepy dermatologii i alergologii 2022; (39(4)):704-707 doi:10.5114/ada.2021.109081.

A case of chronic spontaneous urticaria unresponsive to ligelizumab successfully treated with omalizumab.

Russo F, Cortonesi G, Lazzeri L, et al.

Dermatologic therapy 2022; (35(11)):e15859 doi:10.1111/dth.15859.

The Benefit of Complete Response to Treatment in Patients With Chronic Spontaneous Urticaria-CURE Results.

Kolkhir P, Laires PA, Salameh P, et al.

The journal of allergy and clinical immunology. In practice 2023; (11(2)):610-620.e5 doi:10.1016/j.jaip.2022.11.016.

Biologicals in Treatment of Chronic Urticaria: A Narrative Review.

Mustari AP, Bishnoi A, Kumaran MS

Indian dermatology online journal 2023; (14(1)):9-20 doi:10.4103/idoj.idoj_145_22.

Efficacy and Safety of Up-dosed Second-generation Antihistamines in Uncontrolled Chronic Spontaneous Urticaria: A Review.

Podder I, Dhabal A, Chakraborty SS

The Journal of clinical and aesthetic dermatology 2023; (16(3)):44-50.

Urticarial Vasculitis Differs From Chronic Spontaneous Urticaria in Time to Diagnosis, Clinical Presentation, and Need for Anti-Inflammatory Treatment: An International Prospective UCARE Study.

Bonnekoh H, Jelden-Thurm J, Allenova A, et al.

The journal of allergy and clinical immunology. In practice 2023; (11(9)):2900-2910.e21 doi:10.1016/j.jaip.2023.06.030.

Study on Autoimmune Thyroid Disorders in Chronic Spontaneous Urticaria at a Tertiary Care Central Rural Hospital in India.

Pendam M, Madke B, Singh A, Jawade S

Cureus 2023; (15(5)):e39398 doi:10.7759/cureus.39398.

Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status.

Casale TB, Gimenez-Arnau AM, Bernstein JA, et al.

Dermatology and therapy 2023; (13(11)):2573-2588 doi:10.1007/s13555-023-01040-9.

Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi survey.

Krause K, Bonnekoh H, Jelden-Thurm J, et al.

Clinical and translational allergy 2023; (13(10)):e12305 doi:10.1002/clt2.12305.

A comparative analysis of chronic inducible urticaria in 423 patients: Clinical and laboratory features and comorbid conditions.

Ornek Ozdemir S, Kuteyla Can P, Degirmentepe EN, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2024; (38(3)):513-520 doi:10.1111/jdv.19637.

Comorbid Inducible Urticaria Is Linked to Non-Autoimmune Chronic Spontaneous Urticaria: CURE Insights.

Kovalkova E, Fomina D, Borzova E, et al.

The journal of allergy and clinical immunology. In practice 2024; (12(2)):482-490.e1 doi:10.1016/j.jaip.2023.11.029.

Biomarkers of Autoimmune Chronic Spontaneous Urticaria.

Larenas-Linnemann D

Current allergy and asthma reports 2023; (23(12)):655-664 doi:10.1007/s11882-023-01117-7.

Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials.

Maurer M, Casale TB, Saini SS, et al.

The Journal of allergy and clinical immunology 2024; (154(1)):184-194 doi:10.1016/j.jaci.2024.01.028.

Cold-induced anaphylaxis triggered by drinking cold water.

Alrafiaah AS, Netchiporouk E, Ben-Shoshan M

Allergologia et immunopathologia 2024; (52(2)):45-47 doi:10.15586/aei.v52i2.1041.

The relationship between sleep quality and chronotype differences and urticaria severity in patients with chronic spontaneous urticaria.

Gurel G, Guler D, Guler HA, et al.

Acta dermatovenerologica Alpina, Pannonica, et Adriatica 2024; (33(1)):7-11.

A Practical Approach to Diagnosing and Managing Chronic Spontaneous Urticaria.

Friedman A, Kwatra SG, Yosipovitch G

Dermatology and therapy 2024; (14(6)):1371-1387 doi:10.1007/s13555-024-01173-5.

The effectiveness of omalizumab therapy in patients with chronic spontaneous urticaria: the experience of a single-centre study in Poland.

Lesiak A, Bień N, Lipińska K, et al.

Postepy dermatologii i alergologii 2024; (41(3)):301-305 doi:10.5114/ada.2024.141139.

Dupilumab Reduces Urticaria Activity, Itch, and Hives in Patients with Chronic Spontaneous Urticaria Regardless of Baseline Serum Immunoglobulin E Levels.

Maurer M, Casale TB, Saini SS, et al.

Dermatology and therapy 2024; (14(9)):2427-2441 doi:10.1007/s13555-024-01231-y.

Chronic Spontaneous Urticaria: A Review.

Kolkhir P, Bonnekoh H, Metz M, Maurer M

JAMA 2024; (332(17)):1464-1477 doi:10.1001/jama.2024.15568.

Omalizumab for the Treatment of Chronic Spontaneous Urticaria in Adults and Adolescents: An Eight-Year Real-Life Experience.

Calzari P, Chiei Gallo A, Barei F, et al.

Journal of clinical medicine 2024; (13(18)) doi:10.3390/jcm13185610.

Key differences between chronic inducible and spontaneous urticaria.

Bizjak M, Košnik M

Frontiers in allergy 2024; (5()):1487831 doi:10.3389/falgy.2024.1487831.

Patient and physician perspectives on disease burden in chronic spontaneous urticaria: A real-world US survey.

Mosnaim G, Patil D, Kuruvilla M, et al.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2025; (134(3)):315-323.e3 doi:10.1016/j.anai.2024.11.028.

Cost-effective omalizumab dosage for chronic urticaria: a systematic review and network meta-analysis.

Tajerian A, Pourvali A, Khoshkhui M, et al.

Archives of dermatological research.. 2024; (317(1)):131 doi:10.1007/s00403-024-03629-2.

Chronic spontaneous urticaria remission definition and therapy stepping down: World Allergy Organization position paper.

Sánchez J, Pite H, Gómez RM, et al.

The Journal of allergy and clinical immunology 2025; (155(3)):1050-1056.e2 doi:10.1016/j.jaci.2024.11.039.

Anti-KIT Barzolvolimab for Chronic Spontaneous Urticaria.

Maurer M, Metz M, Anderson J, et al.

Allergy 2025; (80(8)):2178-2186 doi:10.1111/all.16598.

Chronic spontaneous urticaria and chronic inducible urticaria.

Lee R, Bernstein JA

The Journal of allergy and clinical immunology 2025; (156(3)):546-556 doi:10.1016/j.jaci.2025.05.019.

Omalizumab in pediatric chronic spontaneous urticaria: A systematic review and meta-analysis of efficacy and safety.

Alomari O, Ozceker D, Mokresh ME, et al.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2025; (36(6)):e70132 doi:10.1111/pai.70132.

Exploring treatment options for pediatric refractory chronic urticaria.

Kostara M, Kosmeri C, Kocatürk E, et al.

Expert review of clinical immunology 2025; (21(8)):991-1001 doi:10.1080/1744666X.2025.2538897.

A Comparison of Chronic Spontaneous Urticaria Clinical Characteristics and Management between Canadian and Israeli Adults.

Peri K, Khalaf R, Baum A, et al.

International archives of allergy and immunology 2026; (187(4)):346-351 doi:10.1159/000547551.

Chronic spontaneous urticaria: update on pathogenesis and therapeutic implications.

Criado PR, Criado RFJ, Miot HA, et al.

Anais brasileiros de dermatologia 2025; (100(5)):501198 doi:10.1016/j.abd.2025.501198.

Clinical and quality of life improvement after bilastine treatment among patients with autoimmune chronic spontaneous urticaria.

Nguyen MTT, Le MH, Vu MN, et al.

PloS one 2025; (20(8)):e0326445 doi:10.1371/journal.pone.0326445.

T Cell/Mast Cell Crosstalk in the Skin of Patients Suffering From Immune-Mediated Diseases, Focusing on Chronic Spontaneous Urticaria.

Toubi E, Mubariki R, Vadasz Z

Clinical and translational allergy 2026; (16(1)):e70145 doi:10.1002/clt2.70145.

Diagnostic Delay in Patients With Chronic Urticaria: Results From the Chronic Urticaria Registry (CURE).

Muñoz M, Salameh P, Zajac M, et al.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2026; (56(4)):411-420 doi:10.1111/cea.70215.

Remibrutinib: First Approval.

Fung S

Drugs 2026; (86(3)):403-410 doi:10.1007/s40265-025-02281-y.

Remibrutinib Showed a Favorable Safety Profile and Sustained Efficacy in Japanese Patients with Chronic Spontaneous Urticaria Over 52 Weeks.

Hayama K, Chinuki Y, Yagami A, et al.

Dermatology and therapy 2026; (16(3)):1707-1721 doi:10.1007/s13555-026-01666-5.

An Assessment of Melatonin Levels in the Saliva of Patients with Chronic Urticaria in Comparison with Their Sleep Quality and Dermatologic Quality of Life.

Bešlić I, Vrtarić A, Škrinjar I, et al.

Clinics and practice 2026; (16(2)) doi:10.3390/clinpract16020036.

Correlation of disease activity (Urticaria Activity Score over 7 Days) and quality of life (Chronic Urticaria Quality of Life Questionnaire) in patients with chronic spontaneous urticaria: A prospective observational study.

Dash M, Ayub A, Vasudevan B, Sood A

Allergy and asthma proceedings 2026; (47(4)):e57-e64 doi:10.2500/aap.2026.47.260027.

[Treatment of mast cell-mediated angioedema].

Smola A, Lochbaum R

Dermatologie (Heidelberg, Germany) 2026; doi:10.1007/s00105-026-05753-8.